Live feed08:00:00·1536dPRReleasevia QuantisnowUS FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCERByQuantisnow·Wall Street's wire, on your screen.KZIA· Kazia Therapeutics LimitedHealth Care
